Work

Chagas Disease in the United States: a Public Health Approach

Year: 2019

Type: review

Abstract: infections in migrants from Latin America vastly outnumber locally acquired human cases. Benznidazole is now FDA approved, and clinical and public health efforts are under way by researchers and health departments in a number of states. Making progress will require efforts to improve awareness among providers and patients, data on diagnostic test performance and expanded availability of confirmatory testing, and evidence-based strategies to improve access to appropriate management of Chagas disease in the United States.

Source: Clinical Microbiology Reviews

DOI: 10.1128/cmr.00023-19

Authors: Caryn Bern, Louisa A. Messenger, Jeffrey D. Whitman, James H. Maguire

Institutions: University of California, San Francisco, London School of Hygiene & Tropical Medicine, Brigham and Women's Hospital, Harvard University

Language: English

Topic: Trypanosoma species research and implications

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2990179674